Tremors, stiffness, bradykinesia (slow movement), and postural instability are all signs of Parkinson's disease. Other symptoms may include a loss of smell, sleep disturbances, constipation, depression, and cognitive impairment. The market for medications for Parkinson's disease was estimated to be worth $5.9 billion globally in 2025; it is anticipated to increase to $11.2 billion by 2028, with a CAGR of 6.8% from 2020 to 2035. Parkinson's disease is a neurodegenerative condition commonly known as idiopathic Parkinsonism.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
